Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology
- PMID: 15465084
- DOI: 10.1016/j.jns.2004.06.015
Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology
Abstract
Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are common forms of dementia in the elderly. The neuropathology of AD and DLB is related to cholinergic dysfunctions, and both alpha4 and alpha7 nicotinic acetylcholine receptor (nAChR) subunits are decreased in several brain areas in both diseases. In this immunohistochemical study, we compared neuronal and astroglial alpha4 and alpha7 subunits in AD, DLB and age-matched controls in the hippocampal formation. The numbers of alpha4 reactive neurons were decreased in layer 3 of the entorhinal cortex of AD and DLB, whereas those of alpha7 reactive neurons were decreased in layer 2 of the subiculum of AD and DLB and in layer 3 of the entorhinal cortex of DLB. In contrast, the intensity of alpha7 reactive neuropil was significantly higher in AD than in controls or DLB in a number of areas of the hippocampus (CA3/4 and stratum granulosum), subiculum and entorhinal cortex. An increase in alpha7 immunoreactivity in AD was also associated with astrocytes. The number of astrocytes double-labelled with alpha7 and glial fibrillary acidic protein (GFAP) antibodies was increased in most areas of the hippocampus and entorhinal cortex in AD compared with controls and DLB. Increased astrocyte alpha7 nAChRs in AD may be associated with inflammatory mechanisms related to degenerative processes specific to this disease.
Similar articles
-
Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.Glia. 2003 Jan 15;41(2):207-11. doi: 10.1002/glia.10132. Glia. 2003. PMID: 12509811
-
High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.Exp Neurol. 2005 Mar;192(1):215-25. doi: 10.1016/j.expneurol.2004.12.015. Exp Neurol. 2005. PMID: 15698636
-
Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study.Neuropathol Appl Neurobiol. 2004 Jun;30(3):243-54. doi: 10.1046/j.0305-1846.2003.00528.x. Neuropathol Appl Neurobiol. 2004. PMID: 15175078
-
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.Dement Geriatr Cogn Disord. 2004;17 Suppl 1:3-14. doi: 10.1159/000074677. Dement Geriatr Cogn Disord. 2004. PMID: 14676464 Review.
-
Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease.FEBS Lett. 2010 May 3;584(9):1856-63. doi: 10.1016/j.febslet.2009.11.036. Epub 2009 Nov 13. FEBS Lett. 2010. PMID: 19914249 Review.
Cited by
-
Advances in Understanding and Managing Alzheimer's Disease: From Pathophysiology to Innovative Therapeutic Strategies.Curr Drug Targets. 2024;25(11):752-774. doi: 10.2174/0113894501320096240627071400. Curr Drug Targets. 2024. PMID: 39039673 Review.
-
Poly (β-amino Ester) Nanoparticles Modified with a Rabies Virus-derived peptide for the Delivery of ASCL1 Across a 3D In Vitro Model of the Blood Brain Barrier.ACS Appl Nano Mater. 2023 Apr 14;6(7):6299-6311. doi: 10.1021/acsanm.3c00651. Epub 2023 Mar 31. ACS Appl Nano Mater. 2023. PMID: 37274933 Free PMC article.
-
The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease.Nat Rev Neurol. 2023 May;19(5):278-288. doi: 10.1038/s41582-023-00792-4. Epub 2023 Mar 28. Nat Rev Neurol. 2023. PMID: 36977843 Review.
-
Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease.Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12753. doi: 10.1111/nan.12753. Epub 2021 Aug 17. Neuropathol Appl Neurobiol. 2022. PMID: 34297416 Free PMC article.
-
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.J Neurochem. 2021 Sep;158(6):1394-1411. doi: 10.1111/jnc.15471. Epub 2021 Aug 6. J Neurochem. 2021. PMID: 34272732 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
